{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:29:43Z","timestamp":1791264583038,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.schres.2016.07.023","type":"journal-article","created":{"date-parts":[[2016,7,31]],"date-time":"2016-07-31T12:08:31Z","timestamp":1469966911000},"page":"349-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0037-7524","authenticated-orcid":false,"given":"Irene","family":"Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cormac J.","family":"Sammon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"McCrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.J.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip J.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin","family":"Nazareth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2016.07.023_bb0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.ede.0000147122.97061.bb","article-title":"Maternal obesity, gestational diabetes, and central nervous system birth defects","volume":"16","author":"Anderson","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.schres.2016.07.023_bb0010","unstructured":"Antipsychotics: risk of extrapyramidal effects or withdrawal symptoms in newborns Drug Safety Update - GOV.UK [WWW Document], n.d. URL https:\/\/www.gov.uk\/drug-safety-update\/antipsychotics-risk-of-extrapyramidal-effects-or-withdrawal-symptoms-in-newborns#further-information (accessed 11.14.15)."},{"key":"10.1016\/j.schres.2016.07.023_bb0015","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform. Prim. Care"},{"key":"10.1016\/j.schres.2016.07.023_bb0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archgenpsychiatry.2011.1870","article-title":"Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects","volume":"69","author":"Boden","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2016.07.023_bb0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/2050-6511-14-38","article-title":"Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance","volume":"14","author":"Brunner","year":"2013","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.schres.2016.07.023_bb0030","first-page":"S86","article-title":"An algorithm to identify practices common to both the GPRD and THIN database","volume":"19","author":"Cai","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.schres.2016.07.023_bb0035","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification","volume":"300","author":"Chisholm","year":"1990","journal-title":"Br. Med. J."},{"key":"10.1016\/j.schres.2016.07.023_bb0040","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/AOG.0000000000000759","article-title":"Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy","volume":"125","author":"Coughlin","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.schres.2016.07.023_bb0045","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/pds.1770","article-title":"Creating medical and drug code lists to identify cases in primary care databases","volume":"18","author":"Dav\u00e9","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.schres.2016.07.023_bb0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4088\/JCP.v66n0307","article-title":"Safety of haloperidol and Penfluridol in pregnancy: a multicenter, prospective, controlled study","volume":"66","author":"Diav-Citrin","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2016.07.023_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.pra.0000351878.45260.94","article-title":"Use and safety of antipsychotic drugs during pregnancy","volume":"15","author":"Einarson","year":"2009","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.schres.2016.07.023_bb0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0022-3476(80)80504-X","article-title":"Small left colon syndrome associated with maternal ingestion of psychotropic drugs","volume":"97","author":"Falterman","year":"1980","journal-title":"J. Pediatr."},{"key":"10.1016\/j.schres.2016.07.023_bb0065","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.289.19.2554","article-title":"Composite outcomes in randomized trials: greater precision but with greater uncertainty?","volume":"289","author":"Freemantle","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2016.07.023_bb0070","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00004714-200008000-00002","article-title":"Olanzapine-exposed pregnancies and lactation: early experience","volume":"20","author":"Goldstein","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2016.07.023_bb0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","article-title":"Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study","volume":"33","author":"Habermann","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2016.07.023_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028725","article-title":"Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995\u20132009","volume":"6","author":"Hayes","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl. 12","key":"10.1016\/j.schres.2016.07.023_bb0085","first-page":"18","article-title":"Weight gain with atypical antipsychotics: evidence and insights","volume":"68","author":"Henderson","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2016.07.023_bb0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/pds.3368","article-title":"Identifying periods of acceptable computer usage in primary care research databases","volume":"22","author":"Horsfall","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.schres.2016.07.023_bb0095","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy","volume":"6","author":"Kallen","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.schres.2016.07.023_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094788","article-title":"A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies","volume":"9","author":"Kulkarni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2016.07.023_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2009.10.011","article-title":"Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?","volume":"116","author":"Lin","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2016.07.023_bb0110","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0895-4356(94)00137-F","article-title":"The VAMP research multi-purpose database in the UK","volume":"48","author":"Lis","year":"1995","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.schres.2016.07.023_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pds.1688","article-title":"The importance of defining periods of complete mortality reporting for research using automated data from primary care","volume":"18","author":"Maguire","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.schres.2016.07.023_bb0120","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1007\/s10995-013-1419-2","article-title":"Patterns of prescription of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort","volume":"18","author":"Margulis","year":"2014","journal-title":"Matern. Child Health J."},{"key":"10.1016\/j.schres.2016.07.023_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006135","article-title":"Prescribing of antipsychotics in UK primary care: a cohort study","volume":"4","author":"Marston","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.schres.2016.07.023_bb0130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","article-title":"Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study","volume":"66","author":"McKenna","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2016.07.023_bb0135","first-page":"233","article-title":"Use of antipsychotic drugs during pregnancy and the risk of adverse birth outcomes: a population-based cohort study","volume":"31","author":"Munk","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2016.07.023_bb0140","series-title":"Antenatal and postnatal mental health: clinical management and service guidance","author":"National Institute for Health and Care Excellence (NICE)","year":"2014"},{"key":"10.1016\/j.schres.2016.07.023_bb0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1192\/bjp.bp.107.041541","article-title":"Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study","volume":"192","author":"Newham","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2016.07.023_bb0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00228-009-0744-2","article-title":"Perception of risk regarding the use of medications and other exposures during pregnancy","volume":"66","author":"Nordeng","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2016.07.023_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007390","article-title":"Women's perception of risks of adverse fetal pregnancy outcomes: a large-scale multinational survey","volume":"5","author":"Petersen","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.schres.2016.07.023_bb0160","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2014.07.034","article-title":"Discontinuation of antipsychotic medication in pregnancy: a cohort study","volume":"159","author":"Petersen","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2016.07.023_bb0165","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/pds.2213","article-title":"National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom","volume":"21","author":"Prah","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.schres.2016.07.023_bb0170","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","article-title":"Maternal use of antipsychotics in early pregnancy and delivery outcome","volume":"28","author":"Reis","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2016.07.023_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003062","article-title":"Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study","volume":"3","author":"Sadowski","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.schres.2016.07.023_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-015-0451-8","article-title":"The characteristics and health needs of pregnant women with schizophrenia compared with bipolar disorder and affective psychoses","volume":"15","author":"Taylor","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2016.07.023_bb0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00737-013-0330-6","article-title":"Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001\u20132007: a population-based study of 585,615 deliveries","volume":"16","author":"Toh","year":"2013","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.schres.2016.07.023_bb0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2009.01425.x","article-title":"Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies","volume":"121","author":"Verdoux","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2016.07.023_bb0195","doi-asserted-by":"crossref","first-page":"h2298","DOI":"10.1136\/bmj.h2298","article-title":"Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study","volume":"350","author":"Vigod","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2016.07.023_bb0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/2042098611435911","article-title":"Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource","volume":"3","author":"Williams","year":"2012","journal-title":"Ther. Adv. Drug Saf."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416303498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416303498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T23:57:03Z","timestamp":1536537423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416303498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":40,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0920996416303498"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.07.023","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}